COMPANY
NOVOPHARM LIMITED
NOVOPHARM LIMITED: marketing authorisation holder for Leuprolide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Leuprolide | LEUPROLIDE ACETATE INJECTION (DIN 02240264), Cancelled Pre Market Regulator Health Canada |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.